Curexo's medical robot business made an operating loss of 2.213 billion won in the third quarter on revenue of 4.724 billion won, according to the company's filing with South Korea's financial regulator, Bloter reports. A year earlier the business had revenue of 8.409 billion won and an operating profit of 223 million won.
In the second quarter the business had made an operating profit of 2.19 billion won on revenue of 12.62 billion won. From one quarter to the next its revenue fell by 62.6%, while its research and development spending rose by 14.8% to 2.746 billion won, or 58.1% of its revenue.
The loss wiped out the profit of the first half: over nine months the medical robot business lost 1.383 billion won, and Curexo as a whole made an operating loss of 352 million won. Its implant and trading businesses made small profits in the quarter, and the company's consolidated operating loss was 1.876 billion won.
Stock grew as sales fell. Medical robot inventory rose by 10.2% from the end of June to 22.156 billion won at the end of September, about 10 billion won of it finished products. Bloter writes that Curexo now has to turn that stock into cash by selling the robots and collecting payment.



